Leader in cell therapy and cell engineering with 25+ years of experience in developing and advancing cell therapy drug candidates from pre-clinical stage to phase I/II clinical trials and in building strong collaborations between academia and industry partners (including CAR T cells, CD34+ hematopoietic cells, dendritic cells, embryonic stem cells and iPS cells).